KKR and Envision completed the transaction after entering into a definitive agreement in June. The deal was valued at $9.9 billion including the assumption of debt. Envision’s stockholders will receive $46 per share of Envision common stock in cash.
As a result of the completion of the transaction, Envision’s stock stopped trading on the New York Stock Exchange before the stock exchange opened on Oct. 11.
More articles on healthcare industry transactions:
Louisiana hospital enters negotiations with Ochsner as LifePoint exits market
For-profit hospital operator M&A update: 17 latest deals involving CHS, Tenet, HCA and LifePoint
OhioHealth to assume management of 84-bed hospital
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.